MX9400038A - Composiciones y metodos para proveer un efecto analgesico mejorado. - Google Patents

Composiciones y metodos para proveer un efecto analgesico mejorado.

Info

Publication number
MX9400038A
MX9400038A MX9400038A MX9400038A MX9400038A MX 9400038 A MX9400038 A MX 9400038A MX 9400038 A MX9400038 A MX 9400038A MX 9400038 A MX9400038 A MX 9400038A MX 9400038 A MX9400038 A MX 9400038A
Authority
MX
Mexico
Prior art keywords
compositions
methods
analgesic effect
improved analgesic
improved
Prior art date
Application number
MX9400038A
Other languages
English (en)
Inventor
Richard Wilfred D Souza
Sekhar Mitra
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of MX9400038A publication Critical patent/MX9400038A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Composiciones y métodos para proveer un efecto analgésico y antiinflamatorio mejorado por medio de la administración de una cantidad segura y eficaz de una composición que comprende un agente analgésico sustancialmente libre de sus antípodas R(-) seleccionado del grupo que consiste de S(+)-ibuprofeno, S(+) flurbiprofeno y S(+)ketoprofeno, sales farmacéuticamente aceptables de estos, y mezclas de estos junto con una cantidad de cafeína suficiente para apresurar el ataque.
MX9400038A 1992-12-21 1994-01-03 Composiciones y metodos para proveer un efecto analgesico mejorado. MX9400038A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US99437192A 1992-12-21 1992-12-21

Publications (1)

Publication Number Publication Date
MX9400038A true MX9400038A (es) 1994-07-29

Family

ID=25540587

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9400038A MX9400038A (es) 1992-12-21 1994-01-03 Composiciones y metodos para proveer un efecto analgesico mejorado.

Country Status (9)

Country Link
EP (1) EP0674517A1 (es)
JP (1) JPH08504818A (es)
CN (1) CN1094615A (es)
AU (1) AU672279B2 (es)
BR (1) BR9307697A (es)
CA (1) CA2149317A1 (es)
MX (1) MX9400038A (es)
PE (1) PE56194A1 (es)
WO (1) WO1994014449A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0717624A1 (en) * 1993-09-07 1996-06-26 The Procter & Gamble Company Compositions containing an amino acid salt of propionic acid non-steroidal anti-inflammatory agents and caffeine
CA2227958A1 (en) * 1995-07-28 1997-02-13 Sekhar Mitra Compositions containing analgesics and antihistamines and methods for treating respiratory disorders
JPH0987174A (ja) * 1995-09-26 1997-03-31 Kobayashi Pharmaceut Co Ltd 鎮痛性および抗炎症性組成物
US6211246B1 (en) * 1999-06-10 2001-04-03 Mcneil-Ppc, Inc. Rapidly absorbed liquid compositions
TWI313598B (en) 2002-12-18 2009-08-21 Wyeth Corp Compositions of non-steroidal anti-inflammatory drugs, decongestants and anti-histamines
ES2358763T3 (es) * 2006-04-28 2011-05-13 Grünenthal GmbH Combinación farmacéutica que comprende 3-(3-dimetilamino-1-etil-2-metilpropil)fenol y un nsaid.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4420483A (en) * 1982-07-22 1983-12-13 Richardson-Vicks, Inc. Analgesic and anti-inflammatory compositions comprising ibuprofen and methods of using same
US4486436A (en) * 1982-07-22 1984-12-04 Analgesic Associates Analgesic and anti-inflammatory compositions comprising caffeine and methods of using same
US4851444A (en) * 1987-07-10 1989-07-25 Analgesic Associates Onset-hastened/enhanced analgesia
WO1991006295A1 (en) * 1989-11-06 1991-05-16 Sepracor, Inc. Analgesic composition containing optically pure s(+) flurbiprofen
AU8764191A (en) * 1990-09-28 1992-04-28 Mcneill-Ppc Inc. Ibuprofen-antihistamine combinations

Also Published As

Publication number Publication date
CA2149317A1 (en) 1994-07-07
AU5899394A (en) 1994-07-19
AU672279B2 (en) 1996-09-26
WO1994014449A1 (en) 1994-07-07
CN1094615A (zh) 1994-11-09
BR9307697A (pt) 1999-05-25
EP0674517A1 (en) 1995-10-04
JPH08504818A (ja) 1996-05-28
PE56194A1 (es) 1995-01-26

Similar Documents

Publication Publication Date Title
PT100963A (pt) Composicoes farmaceuticas para aplicacao topica de elevada penetracao atraves da pele que compreendem certos polimeros nao-ionicos especificos
AR064895A2 (es) Composicion farmaceutica anhidra para el tratamiento de desordenes inducidos por histamina
ES2159591T3 (es) Composicion de liberacion controlada.
ES2192234T3 (es) Composiciones farmaceuticas parenterales conteniendo sales de amonioalquilo de acidos 2-arilpropionicos.
UY26635A1 (es) Métodos sinérgicos y composiciones para el tratamiento del cáncer
ES2082288T3 (es) Composiciones terapeuticas para administracion intranasal de ketorolaco.
ES2116447T3 (es) Una composicion farmaceutica que contiene un sistema definido de lipidos.
ES2041794T3 (es) Composicion aromatica vinilica estabilizada.
ES2038752T3 (es) Procedimiento para preparar acetilenos disustituidos con un grupo fenilo y un grupo heterobiciclico, que tienen actividad de tipo retinoide.
UY26724A1 (es) Métodos y composiciones para tratar el virus de la hepatitis c
CU23226B7 (es) COMPOSICIONES ANALGéSICAS QUE COMPRENDEN COMPUESTOS ANTI-EPILéPTICOS Y ANTINFLAMATORIOS NO ESTEROIDEOS
ES2114931T3 (es) Nuevos esteres esteroidales.
CL2008003941A1 (es) Uso de escitalopram o de una sal farmaceuticamente aceptable del mismo para preparar un medicamento util en el tratamiento del desorden compulsivo obsesivo.
ES2130152T3 (es) Medicamentos para tratar dolencias inflamatorias o para analgesia que contienen un nsaid y ranitidina/citrato de bismuto.
MX9307644A (es) Medicamento que incluye 2-amino-6-n-propil-amino-4,5, 6, 7,-tetrahidrobenzotiazol con efecto antidepresivo.
ATE15596T1 (de) Pharmazeutische mittel.
DE69415018T2 (de) Oralanzuwendende flüssige arzneizubereitung enthaltend 2-(4-isobutylphenyl)propionsäure
ES2032955T3 (es) Sal sodica anhidra cristalina de 5-cloro-3-(2-tenoil)-2-oxindol-1-carboxamida.
IT1272149B (it) Composizione farmeceutiche ad attivita' analgesica
CO4230093A1 (es) Derivados del indol y sus usos medicos
CO5160272A1 (es) Combinacion de cerivastatina y fibratos
MX9400038A (es) Composiciones y metodos para proveer un efecto analgesico mejorado.
MX9400040A (es) Composiciones para tratar trastornos respiratorios.
ES2176702T3 (es) Antimicoticos con alta liberacion de sustancia activa.
ES2084878T3 (es) Sal colina de diclofenac, un procedimiento para su preparacion y composiciones farmaceuticas que lo contienen.